A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19
Clinical trial NCT05249777 · COMPLETED
Trial details
- NCT number
- NCT05249777
- Sponsor
- Sao Thai Duong Joint Stock Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-06
- Primary completion
- 2022-08-05
- Enrollment
- 573
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.